Jean-François Formela
Atlas Venture Partner
investment range
$500k - $5.0m
sweet spot
$2.0m
Jean-François Formela's Past Investments (20)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| IFM Therapeutics | Venture Round | $55.5M | Dec 2019 | |
| IFM Therapeutics | Series A | $27M (Lead) | Jun 2016 | |
| Spero Therapeutics | Series B | $30M (Lead) | Feb 2016 | |
| Intellia Therapeutics | Series B | $70M | Sep 2015 | |
| Spero Therapeutics | Series A | $30M | Jun 2015 | |
| Ataxion | Series A | $17M (Lead) | Mar 2014 | |
| Egalet | Post-IPO Equity | Feb 2014 | ||
| F-star Biotechnology | Series A | $9.4M | Oct 2013 | |
| Annovation BioPharma | Series A | $8M (Lead) | Sep 2012 | |
| Annovation BioPharma | Venture Round | $2M (Lead) | Jul 2012 |
Jean-François Formela's Experience
Partner Atlas Venture1993 - Present
Senior Director Schering-Plough1989 - 1993
Jean-François Formela's Education
Universite de Paris School of Medicine MD
Columbia Business School MBA
Jean-François Formela's Media
No media found for Jean-François Formela.